The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study

Abstract Background Recent literature reported the biological role of C-peptide, but this role is still controversial and unclear. The primary aim of this study was to investigate associations between C-peptide and cardiovascular biomarkers as well as events. Methods A total of 55636 participants wh...

Full description

Bibliographic Details
Main Authors: Shuang-Tong Yan, Jing Sun, Zhao-Yan Gu, Xin-Yu Miao, Li-Chao Ma, Ban-Ruo Sun, Xiao-Min Fu, Hong-Zhou Liu, Guang Yang, Fu-Sheng Fang, Hong Li
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-022-01636-z
_version_ 1797996060793110528
author Shuang-Tong Yan
Jing Sun
Zhao-Yan Gu
Xin-Yu Miao
Li-Chao Ma
Ban-Ruo Sun
Xiao-Min Fu
Hong-Zhou Liu
Guang Yang
Fu-Sheng Fang
Hong Li
author_facet Shuang-Tong Yan
Jing Sun
Zhao-Yan Gu
Xin-Yu Miao
Li-Chao Ma
Ban-Ruo Sun
Xiao-Min Fu
Hong-Zhou Liu
Guang Yang
Fu-Sheng Fang
Hong Li
author_sort Shuang-Tong Yan
collection DOAJ
description Abstract Background Recent literature reported the biological role of C-peptide, but this role is still controversial and unclear. The primary aim of this study was to investigate associations between C-peptide and cardiovascular biomarkers as well as events. Methods A total of 55636 participants who had a health examination from 2017 to 2021 were included. Of them, 6727 participants visited the hospital at least twice. Cardiovascular biomarkers like high-sensitivity C-reactive protein (hs-CRP) and high-sensitivity cardiac troponin T (hs-cTnT) were measured and their relationships with fasting C-peptide were evaluated for all participants. Cardiovascular events were obtained during the last visit and their associations with C-peptide were evaluated for those participants who visited the hospital at least twice. Results Among the included participants, 11.1% had a previous type 2 diabetes mellitus (T2DM). In the participants without previous T2DM, the relationships between fasting C-peptide and hs-CRP and hs-cTnT were negative if the value of fasting C-peptide was < 1.4 ng/mL and positive if the value was ≥ 1.4 ng/mL. These relationships remained significant after adjusting for hemoglobin A1c, insulin resistance index, and its interaction with C-peptide, even if the participants were stratified by glucose metabolism status or levels of insulin resistance index. Hazard ratios of cardiovascular events were first decreased and then increased with the increasing of baseline C-peptide levels, though these associations became unsignificant using the multivariate Cox regression model. Unlike the participants without previous T2DM, the associations of C-peptide with cardiovascular biomarkers and events were not significant in the patients with previous T2DM. Conclusions The associations of C-peptide with cardiovascular biomarkers and events were different between the participants without previous T2DM and those with previous T2DM. The effect of C-peptide on cardiovascular risk may be bidirectional, play a benefit role at a low level, and play a harmful role at a high level in the nondiabetic adults and the patients with newly diagnosed T2DM.
first_indexed 2024-04-11T10:11:31Z
format Article
id doaj.art-2d5efdff63f542f5a9a06216079c1853
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-04-11T10:11:31Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-2d5efdff63f542f5a9a06216079c18532022-12-22T04:30:06ZengBMCCardiovascular Diabetology1475-28402022-10-0121111110.1186/s12933-022-01636-zThe bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort studyShuang-Tong Yan0Jing Sun1Zhao-Yan Gu2Xin-Yu Miao3Li-Chao Ma4Ban-Ruo Sun5Xiao-Min Fu6Hong-Zhou Liu7Guang Yang8Fu-Sheng Fang9Hong Li10Department of Geriatric Endocrinology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General HospitalHealth Management Institute, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General HospitalDepartment of Geriatric Endocrinology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General HospitalDepartment of Geriatric Endocrinology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General HospitalDepartment of Geriatric Endocrinology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General HospitalDepartment of Geriatric Endocrinology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General HospitalDepartment of Endocrinology, The First Medical Center, Chinese PLA General HospitalDepartment of Endocrinology, The First Medical Center, Chinese PLA General HospitalDepartment of Geriatric Nephrology, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General HospitalDepartment of Health Care, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General HospitalHealth Management Institute, The Second Medical Center and National Clinical Research Center for Geriatric Diseases, Chinese PLA General HospitalAbstract Background Recent literature reported the biological role of C-peptide, but this role is still controversial and unclear. The primary aim of this study was to investigate associations between C-peptide and cardiovascular biomarkers as well as events. Methods A total of 55636 participants who had a health examination from 2017 to 2021 were included. Of them, 6727 participants visited the hospital at least twice. Cardiovascular biomarkers like high-sensitivity C-reactive protein (hs-CRP) and high-sensitivity cardiac troponin T (hs-cTnT) were measured and their relationships with fasting C-peptide were evaluated for all participants. Cardiovascular events were obtained during the last visit and their associations with C-peptide were evaluated for those participants who visited the hospital at least twice. Results Among the included participants, 11.1% had a previous type 2 diabetes mellitus (T2DM). In the participants without previous T2DM, the relationships between fasting C-peptide and hs-CRP and hs-cTnT were negative if the value of fasting C-peptide was < 1.4 ng/mL and positive if the value was ≥ 1.4 ng/mL. These relationships remained significant after adjusting for hemoglobin A1c, insulin resistance index, and its interaction with C-peptide, even if the participants were stratified by glucose metabolism status or levels of insulin resistance index. Hazard ratios of cardiovascular events were first decreased and then increased with the increasing of baseline C-peptide levels, though these associations became unsignificant using the multivariate Cox regression model. Unlike the participants without previous T2DM, the associations of C-peptide with cardiovascular biomarkers and events were not significant in the patients with previous T2DM. Conclusions The associations of C-peptide with cardiovascular biomarkers and events were different between the participants without previous T2DM and those with previous T2DM. The effect of C-peptide on cardiovascular risk may be bidirectional, play a benefit role at a low level, and play a harmful role at a high level in the nondiabetic adults and the patients with newly diagnosed T2DM.https://doi.org/10.1186/s12933-022-01636-zC-peptideCardiac troponin TC-reactive proteinBiomarkersCardiovascular eventsDiabetes
spellingShingle Shuang-Tong Yan
Jing Sun
Zhao-Yan Gu
Xin-Yu Miao
Li-Chao Ma
Ban-Ruo Sun
Xiao-Min Fu
Hong-Zhou Liu
Guang Yang
Fu-Sheng Fang
Hong Li
The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study
Cardiovascular Diabetology
C-peptide
Cardiac troponin T
C-reactive protein
Biomarkers
Cardiovascular events
Diabetes
title The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study
title_full The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study
title_fullStr The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study
title_full_unstemmed The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study
title_short The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study
title_sort bidirectional association of c peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus a retrospective cohort study
topic C-peptide
Cardiac troponin T
C-reactive protein
Biomarkers
Cardiovascular events
Diabetes
url https://doi.org/10.1186/s12933-022-01636-z
work_keys_str_mv AT shuangtongyan thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT jingsun thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT zhaoyangu thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT xinyumiao thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT lichaoma thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT banruosun thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT xiaominfu thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT hongzhouliu thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT guangyang thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT fushengfang thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT hongli thebidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT shuangtongyan bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT jingsun bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT zhaoyangu bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT xinyumiao bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT lichaoma bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT banruosun bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT xiaominfu bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT hongzhouliu bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT guangyang bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT fushengfang bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy
AT hongli bidirectionalassociationofcpeptidewithcardiovascularriskinnondiabeticadultsandpatientswithnewlydiagnosedtype2diabetesmellitusaretrospectivecohortstudy